139 related articles for article (PubMed ID: 12353966)
1. Pneumonitis associated with nonsteroidal antiandrogens: presumptive evidence of a class effect.
Bennett CL; Raisch DW; Sartor O
Ann Intern Med; 2002 Oct; 137(7):625. PubMed ID: 12353966
[No Abstract] [Full Text] [Related]
2. [Antiandrogen in prostate cancer].
Maeda O; Usami M
Nihon Rinsho; 2002 Dec; 60 Suppl 11():188-92. PubMed ID: 12599569
[No Abstract] [Full Text] [Related]
3. Pure antiandrogens as monotherapy in prospective studies of prostatic carcinoma.
Schröder FH
Prog Clin Biol Res; 1990; 359():93-103; discussion 105-7. PubMed ID: 2149460
[TBL] [Abstract][Full Text] [Related]
4. The place and the results of monotherapy.
Bonnet P
Acta Urol Belg; 1998 May; 66(2):11-5. PubMed ID: 9633120
[No Abstract] [Full Text] [Related]
5. Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy.
Migliari R; Muscas G; Murru M; Verdacchi T; De Benedetto G; De Angelis M
Arch Ital Urol Androl; 1999 Dec; 71(5):293-302. PubMed ID: 10673793
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function.
Iversen P; Melezinek I; Schmidt A
BJU Int; 2001 Jan; 87(1):47-56. PubMed ID: 11121992
[No Abstract] [Full Text] [Related]
7. Insulin resistance as an adverse effect of leuprolide and bicalutamide treatment.
Paniagua MA; Hirsch IB
J Gerontol A Biol Sci Med Sci; 2005 Oct; 60(10):1283-4. PubMed ID: 16282560
[No Abstract] [Full Text] [Related]
8. Androgen deprivation for prostatic carcinoma: a rationale for choosing components.
Fourcade RO; Chatelain C
Int J Urol; 1998 Jul; 5(4):303-11. PubMed ID: 9712436
[TBL] [Abstract][Full Text] [Related]
9. Antiandrogen monotherapy in the management of advanced prostate cancer.
Kaisary AV
Eur Urol; 1997; 31 Suppl 2():14-9; discussion 24-7. PubMed ID: 9074906
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of the antiandrogens and their efficacy in prostate cancer.
Mahler C; Verhelst J; Denis L
Clin Pharmacokinet; 1998 May; 34(5):405-17. PubMed ID: 9592622
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapeutic prophylaxis of gynecomastia.
Thönnessen D; Wenz F
J Clin Oncol; 2005 Aug; 23(24):5845; author reply 5846-7. PubMed ID: 16110041
[No Abstract] [Full Text] [Related]
12. Depression related to (neo)adjuvant hormonal therapy for prostate cancer.
van Tol-Geerdink JJ; Leer JW; van Lin EN; Schimmel EC; Stalmeier PF
Radiother Oncol; 2011 Feb; 98(2):203-6. PubMed ID: 21256610
[TBL] [Abstract][Full Text] [Related]
13. Nilutamide: an antiandrogen for the treatment of prostate cancer.
Dole EJ; Holdsworth MT
Ann Pharmacother; 1997 Jan; 31(1):65-75. PubMed ID: 8997470
[TBL] [Abstract][Full Text] [Related]
14. Antiandrogens as monotherapy for prostate cancer.
Schröder FH
Eur Urol; 1998; 34 Suppl 3():12-7. PubMed ID: 9854190
[TBL] [Abstract][Full Text] [Related]
15. Interstitial pneumonitis associated with neoadjuvant leuprolide and nilutamide for prostate cancer.
Wieder JA; Soloway MS
J Urol; 1998 Jun; 159(6):2099. PubMed ID: 9598539
[No Abstract] [Full Text] [Related]
16. New indication sought for bicalutamide.
Oncology (Williston Park); 2000 May; 14(5):654, 772. PubMed ID: 10853458
[No Abstract] [Full Text] [Related]
17. Re: Impact of androgen deprivation therapy on volume reduction and lower urinary tract symptoms in patients with prostate cancer.
Shin YS; Lee DS
Low Urin Tract Symptoms; 2020 Sep; 12(3):293-294. PubMed ID: 32924313
[No Abstract] [Full Text] [Related]
18. Escitalopram in treatment of antiandrogen-related mood disturbance in a patient with chronic schizophrenia and adenocarcinoma of the prostate.
Kao LC; Chen LF; Hsu YC; Chuang WC; Chao HL; Chang HA; Kao YC; Chen TY; Tzeng NS
Gen Hosp Psychiatry; 2015; 37(4):e11-2. PubMed ID: 25911327
[No Abstract] [Full Text] [Related]
19. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
[TBL] [Abstract][Full Text] [Related]
20. Antiandrogenic agents as monotherapy in advanced prostatic carcinoma.
Soloway MS; Matzkin H
Cancer; 1993 Feb; 71(3 Suppl):1083-8. PubMed ID: 8428332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
